Atara Biotherapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for ATRA, updated each market day.
ATRA AI Sentiment
AI sees no strong directional signal for Atara Biotherapeutics, Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Atara Biotherapeutics, Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Sector
Exchange
Market Cap
$39,500,290
Cap Tier
Employees
14
Headquarters
THOUSAND OAKS, CA
Listed Since
Oct. 16, 2014
Website
ATRA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ATRA Volatility
Atara Biotherapeutics, Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
